G6PD deficiency is one of the most common enzymatic disorders worldwide, affecting millions of people, particularly in areas where malaria is or was prevalent. This is because the deficiency can offer some protective benefit against malaria, which has led to its increased prevalence in certain populations. Understanding its global distribution is essential for tailoring public health strategies and managing potential toxic exposures.
In conclusion, G6PD deficiency plays a significant role in the field of toxicology due to its impact on drug metabolism and susceptibility to oxidative stress. Through continued research and awareness, toxicologists aim to minimize adverse effects and improve the quality of life for those affected by this condition.
